-
In this interview with Jill Hayden we learn how this review, one of Cochrane’s largest reviews published to date, has led to new ways of working collaboratively and with an increased focus on research integrity. An ongoing update of this review will bring five related Cochrane reviews together into one. You have just completed the Cochrane review...
28 九月 2021
-
A recently published Cochrane review explores what measures can be taken in long-term care facilities to prevent COVID-19 outbreaks. Can non-medicinal measures prevent or reduce SARS-CoV-2 infections in long term care facilities?Key messages
Non-medicinal measures (e.g. visiting restrictions or regular testing) may prevent SARS-CoV-2 infections (...
15 九月 2021
-
In this author interview with Stephanie Weibel and Maria Popp, we find out more about their Cochrane review, Ivermectin for treating and preventing COVID-19. The review currently has an Altmetric Attention Score of more than 7000, which makes it the most talked-about review in the history of the Cochrane Library.Briefly, what is Ivermectin?...
14 九月 2021
-
'SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19' from Cochrane Haematology published today in the Cochrane Library.
Key messages
We do not know whether antibodies (the body’s natural defence against disease) made in a laboratory and all the same as one another (monoclonal) and designed to target COVID-19, are an...
2 九月 2021
-
24 八月 2021
-
16 八月 2021
-
What can individuals do, especially those with long-term breathing problems, to avoid the effects of air pollution?
This recently published Cochrane review explores this question, and we sat down with the lead author of the review to discuss the review findings.
Tell us about this Cochrane review…What did you find out?
The main thing that we...
9 八月 2021
-
Is ivermectin effective for COVID-19?
Key messages
The authors of this Cochrane systematic review, published today by Cochrane Infectious Diseases Group, found no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, but the evidence base is limited.
Evaluation of ivermectin is continuing in 31 ongoing studies;...
28 七月 2021
-
26 七月 2021
-
Recently Cochrane Dementia and Cognitive Improvement published 'Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment.' We spoke with Dr Jenny McCleery, one of the authors of this Cochrane review, a Consultant Psychiatrist at Oxford Health NHS Foundation Trust, and the Joint Coordinating Editor, of Cochrane...
22 七月 2021